NADPH oxidase and guanylate binding protein 5 restrict survival of avirulent type III strains of Toxoplasma gondii in naive macrophages by Matta, Sumit K et al.




NADPH oxidase and guanylate binding protein 5
restrict survival of avirulent type III strains of
Toxoplasma gondii in naive macrophages
Sumit K. Matta
Washington University School of Medicine in St. Louis
Kelley Patten
Washington University School of Medicine
Quiling Wang





See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Matta, Sumit K.; Patten, Kelley; Wang, Quiling; Kim, Bae-Hoon; MacMicking, John D.; and Sibley, L. David, ,"NADPH oxidase and




Sumit K. Matta, Kelley Patten, Quiling Wang, Bae-Hoon Kim, John D. MacMicking, and L. David Sibley
This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/7143
NADPH Oxidase and Guanylate Binding Protein 5 Restrict
Survival of Avirulent Type III Strains of Toxoplasma gondii in
Naive Macrophages
Sumit K. Matta,a Kelley Patten,a* Quiling Wang,a Bae-Hoon Kim,b,c,d,e John D. MacMicking,b,c,d,e L. David Sibleya
aDepartment of Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis,
Missouri, USA
bHoward Hughes Medical Institute, West Haven, Connecticut, USA
cYale Systems Biology Institute, West Haven, Connecticut, USA
dDepartment of Immunobiology, Yale University School of Medicine, West Haven, Connecticut, USA
eDepartment of Microbial Pathogenesis, Yale University School of Medicine, West Haven, Connecticut, USA
ABSTRACT Phagocytic cells are the ﬁrst line of innate defense against intracellular
pathogens, and yet Toxoplasma gondii is renowned for its ability to survive in macro-
phages, although this paradigm is based on virulent type I parasites. Surprisingly, we
ﬁnd that avirulent type III parasites are preferentially cleared in naive macrophages, in-
dependent of gamma interferon (IFN-) activation. The ability of naive macrophages to
clear type III parasites was dependent on enhanced activity of NADPH oxidase (Nox)-
generated reactive oxygen species (ROS) and induction of guanylate binding protein 5
(Gbp5). Macrophages infected with type III parasites (CTG strain) showed a time-
dependent increase in intracellular ROS generation that was higher than that induced by
type I parasites (GT1 strain). The absence of Nox1 or Nox2, gp91 subunit isoforms of the
Nox complex, reversed ROS-mediated clearance of CTG parasites. Consistent with this
ﬁnding, both Nox1/ and Nox2/ mice showed higher susceptibility to CTG infection
than wild-type mice. Additionally, Gbp5 expression was induced upon infection and the
enhanced clearance of CTG strain parasites was reversed in Gbp5/ macrophages. Ex-
pression of a type I ROP18 allele in CTG prevented clearance in naive macrophages, sug-
gesting that it plays a role counteracting Gbp5. Although ROS and Gbp5 have been
linked to activation of the NLRP3 inﬂammasome, clearance of CTG parasites did not rely
on induction of pyroptosis. Collectively, these ﬁndings reveal that not all strains of
T. gondii are adept at avoiding clearance in macrophages and deﬁne new roles for ROS
and Gbps in controlling this important intracellular pathogen.
IMPORTANCE Toxoplasma infections in humans and other mammals are largely
controlled by IFN- produced by the activated adaptive immune system. However,
we still do not completely understand the role of cell-intrinsic functions in control-
ling Toxoplasma or other apicomplexan infections. The present work identiﬁes intrin-
sic activities in naive macrophages in counteracting T. gondii infection. Using an avir-
ulent strain of T. gondii, we highlight the importance of Nox complexes in conferring
protection against parasite infection both in vitro and in vivo. We also identify Gbp5
as a novel macrophage factor involved in limiting intracellular infection by avirulent
strains of T. gondii. The rarity of human infections caused by type III strains suggests
that these mechanisms may also be important in controlling human toxoplasmosis.
These ﬁndings further extend our understanding of host responses and defense
mechanisms that act to control parasitic infections at the cellular level.
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Toxoplasma gondii is an obligate intracellular parasite of the apicomplexan phylum,and it is capable of infecting a wide range of mammals, including humans (1). The
life cycle includes multiple invasive forms (i.e., tachyzoites, bradyzoites, merozoite, and
sporozoites), each of which successfully invades and replicates inside its host cell (2).
The parasite avoids phagocytosis and instead actively invades its host cell and there-
after resides in a stable parasitophorous vacuole (PV), where it replicates (3, 4). The PV
exhibits several notable features that help explain the survival of T. gondii within hostile
cells such as macrophages. First, entry into human macrophages occurs without
eliciting a classical respiratory burst (5). Second, the lumen of the vacuole fails to acidify,
owing to an absence of delivery of proton pumps to the membrane (6). Third, the
vacuole fails to fuse with lysosomes, thus protecting it from their hydrolytic contents
(7). The molecular mechanism by which the PV avoids eliciting host cellular responses
remains undeﬁned but may stem from active invasion and the formation of the PV
membrane by invagination of the plasma membrane (8) and extensive remodeling of
its contents to mask identity (9, 10).
In North America and Europe, the population structure of T. gondii is dominated by
three clonal lineages known as types I, II, and III (11). Although type I strains are highly
studied due to their acute virulence in laboratory mice (12), they are not the major
types found in natural infection. Rather, type II strains, which exhibit intermediate levels
of virulence in laboratory mice, predominate among animal and human infections in
North America and Europe (13–15). Type II strains exhibit intermediate virulence in mice
and yet are capable of causing signiﬁcant disease in humans (13–15). Type III strains are
also common in animals, and yet they are extremely rare in humans (13–15), suggesting
that they either do not cause infection or at least rarely cause disease. The major
differences in mouse virulence among these strain types have been mapped to a
polymorphic family of rhoptry kinases including ROP18 and ROP5 (16). These determi-
nants have been shown to play a major role in combating host defense in gamma
interferon (IFN-)-activated cells, where the acute virulence is attributed to their
composite genotypes (17).
IFN- is the major resistance determinant that is required to control T. gondii
infection in mice (18), and signaling evoked by this cytokine is essential in both
hematopoietic and nonhematopoietic cells (19). At the cellular level, IFN- exerts its
anti-Toxoplasma effect by upregulating a variety of interferon-stimulated genes (ISGs),
including those for immunity-related GTPases (IRGs), guanylate binding proteins (GBPs),
nitric oxide, or autophagy-related clearance, which in turn either control growth or
damage the parasite directly (20–23). IFN--induced Irgs disrupt and damage the
parasitophorous vacuolar membrane (PVM), leading to parasite killing in mouse mac-
rophages, and this pathway is avoided by virulent type I strains (24, 25). Type I parasites
employ ROP18 to phosphorylate Irgs and thus inhibit their recruitment to their vacuole,
thereby preventing their damage and clearance in mouse macrophages (26, 27).
However, type III parasites lack expression of ROP18 and therefore are rapidly
cleared from IFN--activated macrophages, a defect that is restored by complementa-
tion with ROP18 (26, 27). Mouse GBPs are also known to target the PVM in IFN--
activated cells (28), leading to degradation of the parasite (29). Deletion of the GBP
cluster of chromosome 3 makes mice more susceptible to T. gondii infection (30), as
does loss of Gbp1 (31) or Gbp2 (32). ROP18 has also been shown to participate in
defense against Gbps (31), although the mechanism responsible for this activity is
unknown.
Although most Gbps are known to target invading pathogens, Gbp5 can also
assemble the NLRP3 inﬂammasome in the absence of infection, and within infected
cells, such assembly could conceivably take place on or near the pathogen vacuole (33).
In addition, Gbp2 has been shown to function in activation of the AIM2-dependent
inﬂammasome in response to Francisella novicida (34). Inﬂammasomes are cytosolic
oligomeric protein complexes that often consist of Asc, caspase-1, and an NLR or ALR
sensor protein formed in response to cellular danger or pathogen-associated signals.
Upon activation, the inﬂammasome leads to autoproteolysis of procaspase-1 to pro-
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teolytically active caspase-1 that in turn cleaves cytosolic prointerleukin-1 (pro-IL-1)
and pro-IL-18 to secretory IL-1 and IL-18, respectively. These cytokines then drive
downstream signaling to promote antimicrobial function of macrophages and Th1
adaptive immune responses (35, 36). Inﬂammasome activation has been implicated in
controlling T. gondii infection in vivo, where mice lacking NLRP1B (37) or NLRP3 or
caspase-1 (38) are more susceptible to type II parasite infection.
Gbp7 has been implicated in the recruitment and assembly of NADPH oxidase
complexes to mycobacterium-containing phagosomes (39), suggesting that GBPs may
also participate in pathogen control by recruitment of other effector complexes.
NADPH oxidases (Nox) are multimeric enzyme complexes that generate superoxide free
radicals upon activation (40). Although the Nox complex is expressed in almost every
mammalian tissue, its function of producing reactive oxygen species (ROS) in host
defense against pathogens is more pronounced in phagocytes, where the Nox2 isoform
predominates (41). Upon activation, gp91phox (Nox2) and p22phox subunits that
reside in the plasma membrane recruit other cytosolic subunits of the complex (i.e.,
p40phox, p47phox, and p67phox) to convert NADPH to NADP and hence generate
superoxide radicals (41). When activated, Nox rapidly generates elevated production of
ROS (deﬁned as respiratory burst) in response to pattern recognition receptors of
invading pathogens (42). ROS production is dependent on expression of Nox1 and
Nox2 isoforms in murine bone marrow-derived macrophages (BMDMs) that cross-
regulate differentiation proﬁles of macrophages (43). Mutation in genes involved in
NADPH oxidase functioning or assembly causes chronic granulomatous disease (CGD)
in humans that typically results in frequent bacterial or fungal infections (44).
Here, we undertook examination of the fate of avirulent type III strains in naive
macrophages. We were surprised to ﬁnd that the paradigm that T. gondii survives in
macrophages does not apply uniformly to all strains, but rather, type III strains are
highly susceptible to clearance. We demonstrate that in naive macrophages with
avirulent type III T. gondii, parasites induced Nox-dependent ROS production and Gbp5
expression. Both of these factors are involved in clearance of type III parasites from
naive macrophages independent of prior activation with IFN- and independent of
classical inﬂammasome activation that can be primed by LPS (33). These ﬁndings reveal
novel roles for cell-intrinsic factors in controlling intracellular pathogens and suggest
that virulent strains of T. gondii have additional effectors that block these mechanisms.
RESULTS
Clearance of CTG (type III) parasites in naive macrophages. Macrophages pre-
treated with IFN-/lipopolysaccharide (LPS) are well known to clear intracellular type III
parasites efﬁciently (26). In order to test their innate ability to control intracellular
T. gondii infection in the absence of IFN-, unactivated macrophages were infected with
type I (GT1 strain) or type III (CTG strain) parasites at a multiplicity of infection (MOI) of
0.5. The cells were ﬁxed at 30 min and 20 h postinfection, and the percentage of
infected cells was calculated by automated plate-based imaging to acquire data from
many independent microscopic ﬁelds (see Fig. S1 in the supplemental material). The
percentage of CTG-infected RAW 264.7 macrophages was signiﬁcantly reduced by
50% at 20 h compared to 30 min postinfection, whereas the percentage of GT1-
infected macrophages was unaffected (Fig. 1A). We observed a similar enhanced
clearance of the CTG strain in naive bone marrow-derived macrophages (BMDMs),
while GT1 survived signiﬁcantly better (Fig. 1B). This ﬁnding is somewhat surprising, as
T. gondii is generally regarded as a pathogen that survives in naive macrophages, owing
to its ability to actively invade the host cell and avoid phagocytic responses (4).
Toxoplasma gondii is known to actively invade host cells, including macrophages,
and to avoid lysosomal fusion (7). Hence, we considered that this difference in survival
might reﬂect altered uptake and delivery of parasites to lysosomes. LAMP1 recruitment
to parasites was measured to compare relative extents of active invasion and phago-
cytosis of CTG parasites in macrophages, as described previously (45). LAMP1 recruit-
ment to vacuoles containing live parasites, representing active invasion, was much less
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than recruitment to those containing heat-killed, phagocytosed parasites for both GT1
and CTG strains, suggesting that the clearance of CTG was not due to phagocytosis in
naive BMDMs (Fig. 1C).
Autophagy has also been implicated in growth restriction of susceptible T. gondii
strains, albeit in IFN--activated HeLa cells (23). Parasites targeted for destruction by
this pathway become ubiquitinated, recruit autophagy adapters, and are engulfed by
FIG 1 Survival of T. gondii in naive macrophages. (A) Intracellular survival of GT1 (type I) and CTG (type III) parasites in
naive RAW 264.7 cells at 20 h expressed as percentage of initial infection at 0.5 h. (B) Intracellular survival of GT1 (type I)
and CTG (type III) parasites in naive bone marrow-derived macrophages (BMDMs) at 20 h expressed as percentage of initial
infection at 0.5 h. Macrophages were challenged with parasites at an MOI of 0.5, washed, ﬁxed, and stained with SAG1 to
detect parasites and LAMP1 to detect host cell lysosomes (used for identifying host cells in high-content image analysis).
Values represent means  standard errors of the means from three independent replicates with at least 50 ﬁelds per
replicate. By unpaired Student’s t test, * and ** represent signiﬁcant differences at P  0.05 and P  0.01, respectively. (C)
Percentage of LAMP1-positive live or heat-killed GT1 or CTG parasites in BMDMs at 2 h postinfection. Values represent
means  standard errors of the means from three independent replicates. Representative images to the right showing
parasites stained with SAG1 (MAb DG52, red) and costained with LAMP1 (MAb ID4B, green). (D) Percentage of positively
labeled parasites in naive BMDMs at 2 h postinfection. Values represent means  standard errors of the means from three
independent experiments. Representative images to the right showing parasites stained with SAG1 (MAb DG52, red in top
panels) or GRA7 (rabbit Pc, green in bottom panels) and costained with host cell markers LAMP1 (MAb ID4B, green), LAMP2
(rat MAb GL2A7, green), autophagy adapter p62 (guinea pig Pc, red), or ubiquitin FK2 (MAb FK2, red). Bars, 5 m.
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LC3 (23). Hence, we considered that a similar pathway might be triggered in naive
macrophages infected with CTG. However, ubiquitination of the vacuole membrane as
detected by the antibody FK2, which recognizes mono- and polyubiquitinated proteins,
and recruitment of the LC3 adapter p62 were very low on both parasite strains in naive
BMDMs (Fig. 1D). Additionally, the autophagy-associated marker LAMP2 was not ele-
vated on CTG-containing vacuoles in naive BMDMs (Fig. 1D). Taken together, these
ﬁndings demonstrate that the susceptibility of type III parasites in naive macrophages
is not due to enhanced autophagy or lysosomal clearance.
Previous studies on the clearance of T. gondii in IFN--activated macrophages have
demonstrated that the clearance mediated by IRGs and GBPs occurs in the ﬁrst few
hours after infection (26, 31). As such, we examined the kinetics of clearance of CTG
parasites in naive BMDMs. We observed that the percentage of infected macrophages
started to decrease from 6 to 8 h postinfection and decreased linearly up to 24 h
(Fig. 2A). As such, the kinetics of clearance differs substantially from previously char-
acterized pathways. We also examined the morphology of the parasitophorous vacuole
membrane, as previous studies in IFN--activated cells have described a prominent
scalloped appearance of the membrane, prior to rupture, in a process that is medicated
by IRGs and GBPs (24, 26, 31, 46). A majority of parasitophorous vacuoles at early time
points revealed normal cellular architecture of both the vacuole membrane and the
parasite residing within (Fig. 2B). Over time, there was an accumulation of parasites that
showed damage, including loss of the parasitophorous vacuole envelope (Fig. 2C),
blebbing of parasite surface membranes (Fig. 2C), rupture of the parasitophorous
vacuolar membrane with the host cytosol ﬁlling the space (Fig. 2D), and swelling of
FIG 2 Kinetics of CTG strain parasite clearance. (A) Percentage of naive BMDMs that remained infected at
4, 8, 12, and 24 h compared to 0.5 h. Values represent means standard errors of the means for percentage
of infected cells compared to 0.5 h with at least 100 ﬁelds per time point. One-way ANOVA with Tukey’s
multiple comparison between the time points was used to test differences in infection. * and ** indicate
signiﬁcant differences at P  0.05 and P  0.01, respectively. (B to D) Transmission electron microscopy of
CTG parasites in naive BMDMs sampled at intervals from 2 to 12 h postinfection. (B) Normal parasite with
the parasitophorous vacuole. (C) Damaged parasite showing loss of the parasitophorous vacuole mem-
brane and blebbing of the parasite membranes (white arrow). (D) Disrupted parasitophorous vacuole (blue
arrow) and parasite with swollen nuclear envelope (red arrow). Bars, 500 nm.
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internal parasite membranes such as the nuclear envelope (Fig. 2D). However, at no
stage did we observe the scalloped appearance of the parasitophorous vacuole mem-
brane that accompanies Irg-mediated clearance.
In order to elucidate the mechanism for innate clearance of CTG in naive macro-
phages, BMDMs from different mutant mice lacking factors involved in intracellular
pathogen clearance were examined. Naive BMDMs from mutant mice were infected
with CTG strain parasites in vitro, and the survival at 20 h was assessed relative to
infection at 0.5 h, as described above. Naive BMDMs lacking nitric oxide production
(Nos2/), Irg-mediated defense (IrgM3/), or autophagy protein Atg5 (Atg5f/f
LysMCre) failed to reverse the clearance of CTG strain parasites (Fig. 3). These ﬁndings
indicate that nitric oxide production, Irg-mediated defenses, and Atg-related pathways
are unlikely to explain the increased susceptibility of CTG in naive mouse macrophages.
However, BMDMs lacking gp91 (Nox2/; NADPH oxidase) showed signiﬁcant loss of
CTG clearance compared to wild-type cells (Fig. 3). The rescue of CTG parasites in
Nox2/ macrophages suggested that their clearance in naive macrophages is depen-
dent on reactive oxygen species (ROS) induction.
NADPH oxidase mediated ROS production in T. gondii-infected macrophages.
NADPH oxidases in phagocytes are well known to produce ROS as a defense mecha-
nism against invading pathogens (47). Although invasion of human macrophages by
T. gondii proceeds without a ROS burst (5), infection of mouse macrophages with
T. gondii has been shown to produce early ROS (48). Therefore, we tested whether CTG
versus GT1 infection resulted in elevated ROS production in naive macrophages using
luminol-based chemiluminescence. As expected, neither CTG nor GT1 produced ROS as
deﬁned by classical respiratory burst in naive RAW 264.7 macrophages (Fig. 4A) or
BMDMs (Fig. S2). In contrast, incubation of macrophages with zymosan A (ZymA;
50 g/ml), which acts as a Toll-like receptor 2 (TLR2) agonist, produced the expected
ROS burst within a few minutes of incubation (Fig. 4A and S2). Treatment of macro-
phages with diphenyleneiodonium (DPI; 10 M), which acts as an inhibitor of Nox
assembly, abrogated the increase observed with ZymA treatment (Fig. 4A and S2),
indicating that the observed ROS burst was Nox dependent. These results demonstrate
that T. gondii does not trigger activation of the Nox complex in naive mouse macro-
phages during the initial stages of invasion.
To test whether infection induced delayed production of intracellular ROS, we
infected RAW 264.7 macrophages with carboxyﬂuorescein succinimidyl ester (CFSE)-
labeled parasites and monitored intracellular ROS levels by staining with CellROX deep
red. CTG-infected macrophages showed a time-dependent increase in cellular ROS
levels that were elevated compared to GT1 (Fig. 4B). Treatment of RAW 264.7 macro-
FIG 3 Survival of CTG parasites in bone marrow-derived macrophages. (A) Percentage of BMDMs from
wild-type or mutant mice that remained infected at 20 h compared to 0.5 h postinfection. BL/6
represents wild-type C57BL/6 mice. All other mutants are on a similar background. Atg5/ represents
Atg5f/f crossed with LysMCre mice. Each symbol represents an independent biological experiment.
Median values are marked with horizontal bars. Statistical analysis performed using Kruskal-Wallis test
with Dunn’s correction for multiple tests. *, P  0.05.
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phages with LPS (100 g/ml, as a positive control) showed similar increases in ROS
levels with increasing time (Fig. 4B). To conﬁrm that the increase in CellROX staining
was due to ROS, RAW 264.7 macrophages were pretreated with 2 mM N-acetylcysteine
(NAC) and then infected with T. gondii. Pretreatment of macrophages with NAC, which
acts as a cellular antioxidant, led to signiﬁcant decrease of ROS levels in CTG-infected
cells at 9 h postinfection, conﬁrming that the increase in CellROX staining was due to
ROS (Fig. 4C).
Nox1/ and Nox2/ mice are susceptible to CTG infection. Our ﬁndings thus
far suggest that increased clearance of CTG is due to elevated ROS production. To
conﬁrm this model, we were interested in testing whether the reversal of CTG clearance
in Nox2/ macrophages as shown in Fig. 3 was due to a decrease in ROS production.
First, we established that ROS production upon CTG infection was also evident in
wild-type BMDMs at 9 h postinfection and that it was reversed in NAC-pretreated
macrophages (Fig. 5A). Consistent with the above-described model, ROS levels pro-
duced in CTG-infected Nox1/ and Nox2/ macrophages were signiﬁcantly lower
than what was observed in wild-type cells (Fig. 5B). This ﬁnding suggested that both
Nox isoforms are involved in ROS production in BMDMs infected with CTG. Consistent
with this ﬁnding, CTG infection was signiﬁcantly rescued in NAC-pretreated wild-type
FIG 4 Induction of reactive oxygen species (ROS) during T. gondii infection. (A) Luminol detection of ROS activity from
RAW 264.7 macrophages. Samples were incubated with zymosan A (50 g/ml, black) or zymosan A with diphenylenei-
odonium (DPI, 10 M) (gray) or infected with CTG parasites (red) or GT1 parasites (green) at an MOI of 10. (B) CellROX-based
intracellular detection of ROS following treatment of RAW 264.7 macrophages with LPS (100 g/ml, black) or infection with
CFSE-labeled CTG (red) or GT1 (green) parasites (MOI of 3). Cells were stained with CellROX (5 M) for 30 min before
ﬁxation in 4% formaldehyde and imaging on Cytation3. Values represent mean intracellular CellROX intensity (Cy5
channel) standard errors of the means from at least 1,500 cells per sample normalized to uninfected/untreated cells (gray
line) at each respective time point. (C) Histogram analysis of CellROX intensity (log10) in RAW 264.7 macrophages that were
uninfected (UI, black), or infected with CFSE-labeled CTG (red, MOI of 3) or GT1 (green, MOI of 3) parasites and sampled
at 9 h postinfection. For comparison, untreated (UT, solid) and NAC-pretreated (2 mM NAC, dashed) RAW 264.7
macrophages are shown. Representative images are shown to the right depicting CellROX (Cy5, red), parasites (CFSE,
green), and nuclei (Hoechst stain, blue). Unpaired Student’s t test was used to compare ROS levels in uninfected and
CTG-infected RAW 264.7 macrophages. *, signiﬁcant difference between samples at P  0.05. Bars, 10 m.
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macrophages (Fig. 5C). Moreover, clearance of CTG was also signiﬁcantly decreased in
both Nox1/ and Nox2/ macrophages compared to wild-type cells (Fig. 5C).
Nonetheless, these ﬁndings demonstrate that CTG infection of naive macrophages
leads to increased intracellular ROS that depends on both Nox1 and Nox2 isoforms that
contribute to parasite clearance.
FIG 5 ROS-mediated clearance of T. gondii. (A) Histogram of CellROX intensity (log10) in BMDMs that were
uninfected (UI, black) or infected with CTG (red, MOI of 3) or GT1 (green, MOI of 3) parasites and analyzed
at 9 h postinfection. For comparison, untreated (UT, solid) and NAC-pretreated (2 mM NAC, dashed) BMDMs
are shown. (B) ROS levels detected by CellROX staining of CTG-infected wild-type (WT, red), Nox1/
(magenta), or Nox2/ (blue) BMDMs. Unpaired Student’s t test was used to compare ROS levels in
CTG-infected wild-type and Nox1/ or Nox2/ BMDMs. *, signiﬁcant difference between samples at P 
0.05. (C) Percentage of cells remaining infected at 20 h compared to 0.5 h postinfection. BMDMs from
wild-type (WT, ), Nox1/ (), and Nox2/ (Œ) mice were infected with CTG parasites and left untreated
(UT, black) or treated with NAC (2 mM N-acetylcysteine, gray). Values represent means  standard errors
of the means from three independent replicates with at least 50 ﬁelds per replicate. Representative images
to the right are showing nucleus stained with Hoechst stain (100 ng/ml), parasites stained with SAG1 (MAb
DG52, green), and host cells stained with LAMP1 (MAb 1D4B, red). Bar, 10 m. *, signiﬁcant difference
between compared groups at P  0.05 using unpaired Student’s t test. (D) Survival of CTG or GT1 parasites
(detected with SAG1 labeled with Pac Blue) in inﬂammatory macrophages detected with Gr1 and F4/80.
Wild-type (WT), Nox1/, and Nox2/mice were infected with 106 parasites by i.p. injection, and cells were
harvested 2 days later for staining. (E) Kaplan-Meier survival curve of wild-type (WT) (n 49), Nox1/ (n
34), and Nox2/ (n  19) mice. Mice were infected with 104 CTG tachyzoites i.p. Log rank and
Gehan-Breslow-Wilcoxon tests were used to compare survival of wild type (WT) with that of Nox1/ or
Nox2/ mice. *, signiﬁcant difference between compared groups at P  0.05.
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The loss of CTG clearance in Nox-deﬁcient macrophages in vitro suggested that this
response might also be responsible for control of parasites in vivo. To examine this
possibility, wild-type C57BL/6, Nox1/, and Nox2/ mice were challenged by intra-
peritoneal (i.p.) infection and monitored over time. Infection in Gr1-F4/80 cells,
which represent inﬂammatory macrophages recruited during the early phase of infec-
tion (49), was monitored by ﬂow cytometry. There was a signiﬁcant increase of 3- to
7-fold in the percentage of CTG-infected Gr1-F4/80 cells in Nox1/ and Nox2/
mice compared to wild type (Fig. 5D), consistent with these mutants being less able to
control early infection. In contrast, there was a higher percentage of GT1-infected
Gr1-F4/80 cells, consistent with the intrinsic virulence of this strain (26), and this
decreased only slightly in mutant mice compared to wild type, likely due to a higher
inﬂux of macrophages. The increased expansion of CTG in inﬂammatory macrophages
from Nox-deﬁcient mice at early time points also led to different outcomes of infection.
Notably, Nox1/ and Nox2/ mice were signiﬁcantly more susceptible than the
wild-type mice to i.p. infection with CTG as shown by decreased survival (Fig. 5E). Brains
were harvested from surviving mice after 60 days of infection for evaluation of chronic
infection. However, the cyst burden was below the detection threshold limit of ~25
cysts/mouse brain in wild-type, Nox1/, and Nox2/ mice.
Gbp5 contributes to CTG clearance in naive macrophages. Although the ﬁndings
above point to a role for ROS, this pathway only partially explains the defect in CTG as
NAC treatment of either Nox1/ or Nox2/ mutants did not lead to additive effects
(Fig. 5C). As such, we sought other explanations for the enhanced susceptibility of CTG
in naive macrophages. Induction of Gbp1 (31) and Gbp2 (32) during T. gondii infection
is associated with their recruitment onto the PVM and parasite damage, albeit best
characterized in IFN--activated macrophages. However, some Gbps, including Gbp3
and Gbp5, can be expressed in macrophages to a signiﬁcant level independent of IFN-
(32). Therefore, we tested whether any of these factors are induced upon T. gondii
infection of macrophages independent of IFN-. To our surprise, BMDMs infected with
either CTG or GT1 showed signiﬁcant increase in expression of Gbp2, Gbp5, and
Gbp7 mRNA at 20 h postinfection compared to uninfected cells (Fig. 6A). In particular,
Gbp5 mRNA increased up to ~40-fold upon T. gondii infection, whereas Gbp2 and Gbp7
mRNA showed an ~10-fold increase (Fig. 6A). Gbp5 protein levels were also increased
upon CTG or GT1 infection of naive macrophages, although to a lesser extent than
IFN- treatment in wild-type BMDMs (Fig. 6B). The speciﬁcity of the ~65-kDa band of
Gbp5 was conﬁrmed by its absence in cell lysates of Gbp5/ BMDMs (Fig. 6C).
Previous studies have implicated Gbp5 in promoting NLRP3 inﬂammasome assem-
bly and control of intracellular bacteria (33). ROS production has also been implicated
in the NLRP3 inﬂammasome activation (50), although the NADPH oxidase complex is
not required for inﬂammasome activation in response to strong agonists like nigericin
or ATP (51). Therefore, we tested whether inﬂammasome activation occurs upon
T. gondii infection of naive macrophages. Initially, we monitored IL-1 transcripts and
found that infection with T. gondii only slightly altered their levels, while treatment with
LPS greatly increased mRNA levels (Fig. S3A). We then measured IL-1 release to the
supernatant as a marker of NLRP3 inﬂammasome activation. There was no signiﬁcant
increase in IL-1 secretion of either CTG- or GT1-infected naive macrophages (Fig. S3B).
In contrast, LPS-primed macrophages did show signiﬁcant secretion of IL-1 upon
infection with either CTG or GT1 parasites by 20 h postinfection (Fig. S3B). Release of
IL-1 was dependent on both LPS pretreatment and infection, consistent with the
two-step hypothesis for NLRP3 inﬂammasome activation (52). The increase was signif-
icantly reduced upon NAC pretreatment of wild-type macrophages or in Gbp5/ and
Nox2/ macrophages (Fig. S3B). Caspase-1 activation and its release into the super-
natant are another marker for inﬂammasome activation. However, we also did not
observe activated caspase-1 (cleaved 20-kDa caspase-1 fragment) in the supernatant of
CTG- or GT1-infected naive or LPS-primed macrophages (Fig. S4). As expected, treat-
ment with nigericin was able to elicit caspase-1 release in LPS-activated macrophages,
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and this effect was partially abrogated in Gbp5/ macrophages (Fig. S4). Collectively,
these ﬁndings indicate that infection with T. gondii alone is not sufﬁcient to induce
inﬂammasome activation because priming signals are needed for IL-1 mRNA expres-
sion, but when combined with LPS, it provides a signal that drives IL-1 release.
FIG 6 Gbp5 contributes to CTG clearance in naive macrophages. (A) Real-time PCR showing fold induction of
mRNA transcripts in wild-type (WT) and Nox2/ BMDMs infected with CTG or GT1 at 20 h compared to uninfected
cells at 4 h. Comparative CT values were used to evaluate fold change in transcripts using actin as an internal
transcript control. (B) Western blot of cell lysates from uninfected (UI) or T. gondii (CTG or GT1)-infected naive
BMDMs (4 and 20 h) probed for Gbp5 (green) and actin (red). Normalized band intensities (numbers below the gel)
are shown compared to uninfected IFN- (100 U/ml, 16 h)-stimulated BMDMs (lane 6). (C) Western blot of cell
lysates of untreated or IFN- (100 U/ml, 16 h)-treated wild-type (WT) or Gbp5/ BMDMs probed for Gbp5 (green)
and actin (red). (D) Percentage of wild-type (WT) and Gbp5/ BMDMs infected at 20 h compared to 0.5 h. *,
signiﬁcant difference at P  0.05 between CTG-infected wild-type and Gbp5/ BMDMs at 20 h using Student’s
t test. (E) Recruitment of Gbp5 in wild-type BMDMs infected with CTG, GT1, or CTG expressing ROP18 (CTG.ROP18)
at 9 h postinfection. Cells were stained for Gbp5 (rabbit Pc, Gbp5, green), T. gondii (MAb DG52, SAG1, red), and
nuclei (Hoechst stain, 100 ng/ml, blue). Bar, 10 m. DIC, differential inference contrast. (F) Infection of wild-type
(WT), Nox2/, and Gbp5/ BMDMs infected with CTG or ROP18-expressing CTG (CTG.ROP18). Percentage of
wild-type (WT, black bars), Gbp5/ (red bars), and Nox2/ (green bars) macrophages infected at 20 h compared
to 0.5 h. Values represent means  standard errors of the means from at least three independent biological
replicates. *, signiﬁcant difference at P  0.05 between compared groups using Student’s t test.
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Although this pathway is partially dependent on Gbp5 and ROS, it did not lead to cell
death (Fig. S5).
Given the absence of evidence for inﬂammasome-mediated clearance, we sought
evidence that Gbp5 might be directly involved in mediating clearance of CTG in naive
cells. Interestingly, CTG clearance in Gbp5/ macrophages was signiﬁcantly reversed
(Fig. 6D). Despite evidence that Gbp5 contributes to clearance, we observed only
modest evidence for its recruitment to parasitophorous vacuoles containing CTG
(3.1%  2.4% [mean  standard deviation {SD}, n  4] at 9 h postinfection) in naive
macrophages (Fig. 6E). However, Gbp5 recruitment was absent (0%) in either GT1 or
CTG parasites expressing the type I ROP18 allele (CTG.ROP18) (Fig. 6E). Moreover, the
clearance of the CTG.ROP18 strain was also signiﬁcantly less than that of CTG in
wild-type BMDMs and was similar to clearance of CTG in Gbp5/ BMDMs (Fig. 6F).
These ﬁndings suggested that ROP18 expression in type I parasites is involved in
resisting Gbp5-mediated clearance in naive macrophages to Toxoplasma infection and
that Gbp5 can exert its effects in part via mechanisms other than targeting the PV.
DISCUSSION
Toxoplasma gondii is known for its ability to enter and survive in phagocytic cells
where it avoids lysosome fusion and replicates within a sequestered vacuole. Surpris-
ingly, we found that highly avirulent type III strains are rapidly cleared in naive
macrophages, even in the absence of interferon activation. Clearance was associated
with gradual disruption of the PV and damage to the parasites in a process that did not
involve lysosome fusion, recruitment of autophagy adapters, or vesiculation mecha-
nisms that have been described previously. Additionally, there was no effect on parasite
clearance in the absence of different host factors like Atg5, Nos2, or Irgs that are
involved in IFN--mediated growth restriction and killing of T. gondii in murine mac-
rophages. Instead, naive macrophages cleared avirulent type III T. gondii parasites via
induction of cellular ROS. Disruption of the NADPH oxidase complex in Nox1- or
Nox2-deﬁcient cells partially reversed the clearance defect. Nox1- and Nox2-deﬁcient
mice were also more susceptible to infection, indicating that this mechanism partially
accounts for avirulence of type III strains in vivo. In addition, infection of macrophages
leads to upregulation of GBPs, and the clearance of type III parasites was partially
reversed in Gbp5/ macrophages. Although both NADPH oxidase and Gbp5 have
previously been implicated in activation of the NLRP3 inﬂammasome, infected cells did
not undergo caspase-1 cleavage or pyroptosis. These ﬁndings highlight new roles for
the NAPH oxidase and GBPs in control of intracellular pathogens via pathways intrinsic
to naive cells that do not require prior activation by interferons.
Invasion of T. gondii into macrophages results in formation of a parasitophorous
vacuole that fails to acquire markers of endosomes and also does not fuse with
lysosomes (45). This outcome can be modulated by adding antibody to opsonize the
parasite for internalization via Fc receptors (3). Interestingly, the machinery to drive
lysosome fusion is also found in nonphagocytic cells as shown by expression of Fc
receptors, which is sufﬁcient to drive opsonized T. gondii to lysosomes (53). The ability
of T. gondii to avoid lysosome fusion was not responsible for the defect in type III strain
survival and is likely universal to all strains. Additionally, we did not observe an increase
in ubiquitination or recruitment of autophagy adapters that have been linked to control
of intracellular bacterial by a process termed xenophagy (54–56). Instead, the PV
formed normally but then underwent gradual disruption characterized by loss of
integrity of the vacuolar membrane, damage to parasite membrane, and degradation
of internal membrane structures. These features are very different from the scalloped
appearance of the parasitophorous vacuole membrane that accompanies clearance in
IFN--activated cells, a process linked to recruitment of Irgs (26). The recruitment of Irgs
to the PVM is dependent on a noncanonical autophagy pathway and is disrupted in
Atg5/ cells and other components of the core pathway (46, 57). Consistent with a
lack of evidence for PVM vesiculation, the enhanced clearance of type III parasites was
unaltered in Atg5/, IrgM3/, or Nos2/ cells. Although the precise reason for loss
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of type III parasites is uncertain, it may involve damage from ROS and/or transient
association with Gbp5, as discussed below. Regardless of the precise mechanism of
membrane damage, this outcome differs morphologically and kinetically from previ-
ously described pathways for clearance of T. gondii in macrophages.
ROS induction in naive macrophages is associated with production of a respiratory
burst, which is a rapid and elevated increase in production of superoxide free radicals
and H2O2 upon activation of NADPH oxidases in response to early recognition of
pathogens (58). Reversal of CTG clearance in Nox1/ or Nox2/ macrophages
suggests that the parasites are cleared by induction of NADPH oxidase-mediated ROS
in naive macrophages. However, we did not observe a classical respiratory burst, which
typically is evoked very rapidly and reaches high levels, as seen with zymosan stimu-
lation. Rather, ROS production following T. gondii infection was muted in its extent and
delayed, with maximum levels detected at ~9 h postinfection. It remains possible that
the role described here for NADPH oxidase could also be due to mitochondrial
production of ROS, since previous studies have shown that these pathways work
cooperatively in host defense against intracellular bacteria (59). Regardless of the exact
mechanism of ROS production, the role of NADPH oxidase was also seen in vivo where
both Nox1/ and Nox2/ mice showed increased infection of inﬂammatory macro-
phages during early infection with CTG, leading to increased susceptibility compared
with wild-type mice. The reason for the enhanced induction of ROS by type III strains
is uncertain, but numerous genetic differences occur between type I and III strains,
including the polymorphic T. gondii protein GRA7 (17, 60), which has been shown to
elicit Nox2-dependent ROS in BMDMs (61). Prior studies have also suggested a role for
NADPH oxidase during acute infection of mice with type I parasites that elicited ROS
production by infected myeloid inﬂammatory cells during 3 to 4 days postinfection (62).
Additionally, preexposure to ATP can increase ROS upon type I T. gondii infection of
macrophages (63). Collectively, these ﬁndings suggest that ROS production can lead to
control of T. gondii under certain circumstances. Our ﬁndings indicate that type III
strains induce signiﬁcantly higher levels of ROS and that this contributes to their
clearance in naive macrophages.
The observation that susceptible CTG parasites were only partially reversed in
Nox1/ and Nox2/macrophages suggested that some other factor also contributes
to clearance of parasite in naive macrophages. We therefore examined the expression
of other innate effectors that have been implicated in control of T. gondii, including
IRGs and GBPs (64). Expression of Gbp5 was strongly induced upon infection with
T. gondii, while Gbp2 and Gbp7 were induced at lower levels, and no substantial change
was seen in Gbp1 or Irga6. Gbp5 is normally expressed in unstimulated mouse
macrophages, and like other GBPs, it is also induced by interferon treatment (32).
Induction of GBPs upon T. gondii infection occurred independently of addition of
interferon, although the basis for this increased expression is uncertain. Unlike Gbp1
and Gbp2, Gbp5 has not previously been associated with increased recruitment to
T. gondii-containing vacuoles in interferon-activated cells (28). Consistent with this
observation, Gbp5 was detected on only a minority of CTG-containing vacuoles (i.e.,
~3%) in naive macrophages, albeit at higher levels than seen in GT1-infected cells.
Despite its not being strongly recruited to the vacuole, loss of Gbp5 in the knockout led
to the increased survival of CTG parasites in naive macrophages. Hence, it is possible
that Gbp5 plays a role in parasite restriction that is independent of stable association
with the parasite vacuole. A similar ﬁnding has previously been reported for GBP1 in
human cells, where parasite control occurs independently of recruitment to the vacuole
in A549 cells (65). Alternatively, it is possible that recruitment of Gbp5 to T. gondii-
containing vacuoles is transient or that the demise of the compartment is sufﬁciently
rapid that it does not remain stably associated with the membrane. Consistent with the
idea that Gbp5 acts proximal to the parasitophorous vacuole membrane, expression of
ROP18 in the type III CTG strain reversed the enhanced clearance seen in naive
macrophages. ROP18 has previously been shown to mediate resistance to Gbp1 in
interferon-activated macrophages, and this protective effect is thought to occur at the
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parasitophorous vacuole membrane (31). Similarly, expression of ROP18 in CTG para-
sites may block the action of Gbp5, or an associated factor, on the parasitophorous
vacuole membrane, thus protecting the parasite from damage. Distinguishing between
these two mechanisms will require further study to deﬁne the molecular partners of
Gbp5 and to ascertain whether ROP18 acts directly or indirectly to block this host
effector.
Although both NADPH oxidase and Gbp5 were individually important in the control
of CTG clearance in naive macrophages, our studies do not deﬁne whether these
processes operate as separate parallel pathways or if they converge on a common
mechanism. One common process that is inﬂuenced by both cellular ROS and Gbp5 is
NLRP3 inﬂammasome activation (33, 50). Our ﬁndings are only partially consistent with
activation of the inﬂammasome pathway, which normally requires separate priming
and activation steps (52). Infection with type I or type III strain parasites did not drive
IL-1 expression on its own, indicating that the parasites are not able to provide the
normal priming step. However, infection with type I (GT1) or type III (CTG) strain
parasites was able to induce IL-1 release from LPS-treated cells, indicating that
infection can activate the NLRP3 inﬂammasome in cells that have previously been
primed (52). However, we did not detect cleavage and release of caspase-1 or activation
of pyroptosis in T. gondii-infected cells even following LPS priming, suggesting that
infection with these strains does not result in classical inﬂammasome activation.
Interestingly, in the present study both Nox2 and Gbp5 were required for optimal IL-1
release in LPS-primed and infected cells, consistent with previous ﬁndings that these
processes regulate the NLRP3 inﬂammasome (33, 50). Thus, one model to explain the
roles for NADPH oxidase and Gbp5 in restricting survival of type III strains of T. gondii
is that they collectively activate an inﬂammasome-like process, albeit not one that leads
to cell death. This observation agrees with several previous studies that used type II
strain parasites to infect BMDMs in vitro and found that IL-1 gets secreted from primed
cells without inducing pyroptosis (37, 38). Although engagement of the inﬂammasome
complex does not appear to induce cell death in the murine system, it nonetheless has
been shown to promote parasite control in vivo, an effect that may relate to processing
of cytokines, including IL-1 (37) and IL-18 (38). Thus, the enhanced susceptibility of
type III strains in vivo may stem from both the increased susceptibility to clearance in
naive macrophage and downstream mediators that inﬂuence immunity.
Type III strains are highly susceptible to clearance by IRGs and GBPs in activated
mouse macrophages, in part due to their lack of expression of the parasite effector
ROP18 (26, 27). IRGs (66, 67) and GBPs (64) are strongly induced following exposure to
IFN-, and they provide the major mechanism of resistance in the mouse following
activation of the immune response. Collectively, the susceptibility of type III strains to
clearance in naive cells, as reported here, and in IFN--activated cells, as reported
previously, contributes to their profound avirulence in the murine system. Type II
strains, which have intermediate virulence in mice, were not susceptible to clearance in
naive cells (S. K. Matta, unpublished data), although we have not examined the
consequence of loss of ROP18 in this genetic background. Type III strains may also be
susceptible to ROS in human cells, although infection of human monocyte-derived
macrophages with type I strains of T. gondii has been reported to not trigger a strong
respiratory burst (5). Moreover, chronic granulomatous disease (CGD) patients, who lack
a functional PHOX oxidase complex, are not known to be more susceptible to toxo-
plasmosis (68), suggesting that there are other intrinsic mechanisms for control of this
parasite in human cells. Deﬁning the roles of various pathways in human cells, including
the role of additional GBPs, in the control of T. gondii remains an important goal for
future studies.
Although T. gondii is considered to be highly adapted to survive in phagocytic cells,
including macrophages, our ﬁndings indicate that this is not a universal attribute.
Rather, type III strains are readily cleared from naive macrophages, a property that may
underlie their avirulence in mice, and possibly the rarity of infections caused in humans.
We have identiﬁed Nox-mediated ROS generation and Gbp5 as novel factors involved
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in regulating intracellular survival of avirulent type III parasites within macrophages.
These factors may be linked by a common involvement of the NLRP3 inﬂammasome,
although restriction of parasite survival does not rely on activating pyroptosis. To-
gether, these factors act independently of interferon activation, suggesting that they
provide an autonomous system for cell-intrinsic control of intracellular infection.
MATERIALS AND METHODS
Reagents and antibodies. Zymosan A (ZymA), DPI, luminol, horseradish peroxidase (HRP), lipopoly-
saccharide (LPS), and N-acetylcysteine (NAC) were obtained from Sigma (St. Louis, MO, USA). CellROX
deep red, goat anti-mouse IgG, goat anti-rat IgG, goat anti-rabbit, or goat anti-guinea pig secondary
antibodies conjugated to Alexa 594 or Alexa 488 were obtained from Life Technologies (Grand Island, NY,
USA). Carboxyﬂuorescein succinimidyl ester (CFSE) was obtained from Thermo Fisher Scientiﬁc (Waltham,
MA, USA). Rabbit polyclonal (Pc) anti-Gbp5 antibody was obtained from Proteintech Group (Rosemont,
IL, USA). Cy5-labeled Gr1, ﬂuorescein isothiocyanate (FITC)-labeled F4/80, and phycoerythrin (PE)-labeled
B220 were obtained from BD Biosciences (San Jose, CA, USA). Mouse anti-actin (C4 clone) antibody was
obtained from Millipore (MA, USA). Mouse monoclonal antibody (MAb) anti-caspase-1 (p20) was ob-
tained from Adipogen Life Sciences (San Diego, CA). Goat anti-rabbit IgG IR800 and anti-mouse IgG IR700
were obtained from Li-Cor Biosciences (Lincoln, NE, USA). T. gondii parasites were stained with mouse
MAb DG52 against the surface antigen SAG1 (69). MAb DG52 was labeled with Paciﬁc Blue (Pac Blue) dye
using a protein labeling kit (Invitrogen) to generate Pac Blue-labeled antibody for parasite detection by
ﬂow cytometry. GRA7 was detected using a rabbit Pc serum described previously (60). LAMP1 was
localized with rat MAb ID4B, obtained from the Developmental Studies Hybridoma Bank (http://dshb
.biology.uiowa.edu). Guinea pig polyclonal anti-p62 was obtained from Progen (Heidelberg, Germany).
Mouse MAb FK2 against polyubiquitin and monoubiquitin was obtained from EMD Millipore Corpora-
tion (Billerica, MA). Anti-LAMP2 (rat MAb GL2A7) was obtained from Abcam. Fluorescein isothiocyanate
(FITC)-conjugated Dolichos biﬂorus lectin (DBL) was obtained from Vector Laboratories (Burlingame, CA,
USA).
Parasite and macrophage culture. Type I (GT1, ATCC 50853) and type III (CTG, ATCC 50842) strains
of T. gondii were grown as tachyzoites in human foreskin ﬁbroblasts (HFFs; obtained from the laboratory
of John Boothroyd, Stanford University) as described previously (70). Parasites for all experiments were
harvested shortly after natural egress, puriﬁed by passage through a 20-gauge needle, and separated
from host cell debris using 3.0-m polycarbonate Nuclepore ﬁlters (Whatman). RAW 264.7 macrophage
cells (ATCC TIB-71) were maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM; Life Technologies)
with 10% fetal bovine serum (FBS; Life Technologies) and cultured at 37°C and 5% CO2. Bone marrow-
derived macrophages (BMDMs) were isolated from the femurs of adult mice, as described previously (71).
BMDMs were harvested in DMEM containing 20% L929 conditioned medium, 10% FBS, and 5% horse
serum in a 100-mm by 20-mm untreated polystyrene culture dish (Corning). After a week of culture, the
cells were maintained in DMEM containing 10% L929 conditioned medium, 10% FBS, and 5% horse
serum. For experiments, BMDMs were rinsed in calcium-magnesium-free phosphate-buffered saline
(PBS), harvested by incubation with 1.25 mM trypsin for 20 min, and seeded in DMEM containing 10%
FBS. All strains and host cell lines were determined to be mycoplasma negative using the e-Myco Plus
kit (Intron Biotechnology).
Animals. Mice were housed and bred locally at Washington University in an Association for
Assessment and Accreditation of Laboratory Animal Care-approved facility. Animal studies were con-
ducted according to the U.S Public Health Service Policy on Humane Care and Use of Laboratory Animals.
All mice were on a C57BL/6 background. C57BL/6 wild-type, Nos2/, and Nox1/ mice were
purchased from Jackson Laboratories. Nox2/ mice, also referred to as X-CGD or gp91/ mice (72),
were provided by M. Dinauer, Washington University in St. Louis. Gbp5/ mice were provided by the
laboratory of John D. MacMicking, Yale University School of Medicine. IrgM3/ mice (66) were obtained
from Greg Taylor, Duke University. Atg5f/f mice were crossed with LysMCre mice and genotyped as
described previously (73, 74).
For survival assays, 8- to 12-week-old mice were injected with 104 CTG tachyzoites i.p., and survival
was monitored for 60 days. For in vivo parasite clearance, 106 parasites were injected i.p. into 8- to
12-week-old mice. Mice were sacriﬁced 48 h postinfection, and peritoneal cells were isolated by lavage
with ice-cold PBS. Cells were ﬁxed with 4% formaldehyde and stained with FITC-F4/80 and Cy5-Gr1 to
identify inﬂammatory macrophages, Pac Blue-DG52 to label parasites, and PE-B220 to gate out B cells.
The fraction of parasite-positive Gr1-F4/80 cells was used to monitor the burden of parasite infection
based on acquisition of 50,000 events per sample on a FACSCanto II ﬂow cytometer at the Flow
Cytometry research core, Department of Pathology and Immunology, Washington University in St. Louis.
Data were analyzed using the ﬂowCore R package (75).
Chronic cyst burden estimation. Surviving mice after 60 days of infection with the CTG strain were
sacriﬁced, and their brains were harvested in 1 ml of 6% (vol/vol) formaldehyde and 0.25% (vol/vol) Triton
X-100 in cold PBS. Brain homogenate was prepared by passing the tissue multiple times through a
16-gauge needle. The homogenates were then centrifuged at 400  g for 10 min at 4°C. The pellet was
then blocked with 10% (vol/vol) normal goat serum in PBS at 4°C for 1 h. The homogenate was then
centrifuged at 400  g for 10 min, and the pellet was resuspended with 20 g/ml FITC-conjugated
Dolichos biﬂorus lectin (DBL) in 10% goat serum for 2 h at room temperature. The homogenates were
washed twice with 10% goat serum and resuspended in 1 ml PBS for microscopic examination. Each
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sample was examined using three aliquots of 12.5 l each using an epiﬂuorescence microscope
equipped with an FITC emission channel.
Immunoﬂuorescence microscopy. The cells were ﬁxed in 4% formaldehyde for 20 min at room
temperature, blocked using 5% FBS and 5% normal goat serum with 0.02% saponin in PBS for 30 min,
and incubated with primary antibodies in 1% FBS with 0.02% saponin in PBS for 90 min. Cells were
washed three times with PBS and incubated with Alexa-conjugated secondary antibodies and Hoechst
stain (100 ng/ml) to stain nuclei (Life Technologies) for 30 min. Cells were then washed three times with
PBS followed by image acquisition. Parasites and macrophages were labeled with 1:1,000 DG52 and rat
1:1,000 anti-LAMP1 as primary antibodies followed by 1:1,000 anti-mouse IgG-Alexa 488 and anti-rat
IgG-Alexa 594 as secondary antibodies. Cells plated in 96-well CLEAR black plates (Greiner Bio
International) for Toxoplasma survival assay were imaged on a Cytation3 cell imaging multimode reader
(BioTek) using a 20 objective (numerical aperture [NA], 0.45). Cells plated on coverslips for Gbp5
localization were imaged on an LSM880 confocal laser scanning microscope (Carl Zeiss) using a 63
objective (NA, 1.4) as part of the Microbiology Imaging Facility, Washington University in St. Louis.
Transmission electron microscopy. For ultrastructural analyses, samples were ﬁxed in 2%
paraformaldehyde-2.5% glutaraldehyde (Polysciences Inc., Warrington, PA) in 100 mM sodium cacodylate
buffer, pH 7.2, for 2 h at room temperature and then overnight at 4°C. Samples were washed in sodium
cacodylate buffer at room temperature and postinfection ﬁxed in 1% osmium tetroxide (Polysciences
Inc.) for 1 h. Samples were then rinsed extensively in distilled water (dH2O) prior to en bloc staining with
1% aqueous uranyl acetate (Ted Pella, Redding, CA) for 1 h. Following several rinses in dH2O, samples
were dehydrated in a graded series of ethanol and embedded in Eponate 12 resin (Ted Pella Inc.).
Sections of 95 nm were cut with a Leica Ultracut UCT ultramicrotome (Leica Microsystems Inc.,
Bannockburn, IL), stained with uranyl acetate and lead citrate, and viewed on a JEOL 1200 EX transmis-
sion electron microscope (JEOL USA Inc., Peabody, MA) equipped with an AMT 8-megapixel digital
camera and AMT Image Capture Engine V602 software (Advanced Microscopy Techniques, Woburn, MA)
as part of the Microbiology Imaging Facility, Washington University in St. Louis.
Toxoplasma intracellular survival assay. RAW 264.7 cells or BMDMs were seeded in 96-well
CLEAR black plates (Greiner Bio International) 24 h prior to infection. Cells were infected with CTG or
GT1 at an MOI of 0.5 for 30 min followed by three PBS washes to remove extracellular parasites. Cells
were ﬁxed at 30 min and 20 h postinfection using 4% formaldehyde and stained to detect host cell
(anti-LAMP1) and parasites (anti-SAG1) followed by Alexa-conjugated secondary antibodies. Images were
acquired at 20 on the Cytation3 imager, and the percentage of infected cells per ﬁeld was determined
using CellProﬁler 2.1.1 (see Fig. S1 in the supplemental material). For RAW 264.7 macrophages, the
number of infected cells at each time point was used to calculate the percentage of infection. Data from
at least 50 ﬁelds per experiment were used to calculate the percent decrease in infected cells at 20 h
versus 30 min postinfection.
Luminol-based respiratory burst assay. One million RAW 264.7 cells or BMDMs per 100 l of
phenol-free DMEM were warmed to 37°C for 15 min. Luminol and horseradish peroxidase were added
to cells at ﬁnal concentrations of 200 M and 20 U/ml, respectively, and incubated for 5 min at 37°C. The
cells were then infected with parasites at an MOI of 10 or incubated with 50 g/ml ZymA (with or without
10 M DPI). Chemiluminescence was then recorded as relative light units (RLU) per second in real time
for the next 2 h using the Cytation3 imager and analyzed using Gen5 software.
Intracellular ROS measurement assay. RAW 264.7 cells or BMDMs were seeded in 96-well CLEAR
black plates 24 h prior to infection. Parasites were labeled by incubation with 2.5 M carboxyﬂuorescein
succinimidyl ester (CFSE) for 5 min before infecting macrophages at an MOI of 2 for 30 min. Cells were
then washed three times with PBS to remove extracellular parasites. At different time intervals postin-
fection, cells were stained with 5 M CellROX deep red (Thermo Fisher Scientiﬁc) and Hoechst stain
(100 ng/ml) for 30 min. After washing with PBS, images were acquired at 20 on the Cytation3 imager.
After illumination correction of each image, integrated emission intensity per cell in the Cy5 channel was
calculated for uninfected and infected cells across many ﬁelds. Histograms of the Cy5 intensity values
were generated from at least 2,000 cells per sample.
Western blotting. Cell lysates of BMDMs were prepared using CellLytic M (Sigma) mixed with
Complete Mini protease inhibitor cocktail (Roche). Cell supernatants were collected after centrifugation
at 6,000 g for 10 min at room temperature (RT) to avoid cell debris. Total protein was measured in each
sample using the bicinchoninic acid (BCA) protein assay kit (Pierce, Thermo Fisher Scientiﬁc). Samples
were boiled at 95°C for 15 min in Laemmli buffer containing 100 mM dithiothreitol (DTT). Samples were
separated using SDS-PAGE and transferred onto a nitrocellulose membrane. The membrane was blocked
in a 1:1 mixture of Odyssey blocking buffer (OBB; Li-Cor Biosciences) and PBS overnight at 4°C. The
membrane was incubated with rabbit polyclonal anti-Gbp5 or anti-caspase-1 at 1:1,000 and mouse
anti-actin (C4 clone; Millipore) at 1:4,000 for 2 h at RT in a 1:1 mixture of Odyssey blocking buffer and PBS
with 0.1% Tween 20 (PBS-Tween). The blot was washed three times for 5 min each with PBS-Tween and
incubated with anti-rabbit IgG IR800 and anti-mouse IgG IR700 at 1:15,000 for 2 h at RT in a 1:1 mixture
of Odyssey blocking buffer and PBS-Tween. The blot was washed three times for 5 min each with
PBS-Tween followed by infrared imaging on a Li-Cor Odyssey imaging system. Band intensities were
calculated using the Odyssey software.
Real-time PCR. Samples were lysed, and RNA was extracted using the Qiagen RNeasy minikit per the
manufacturer’s instructions. cDNA was prepared using the Bio-Rad iScript cDNA synthesis kit per the
manufacturer’s instructions. Real-time PCR of all the genes was performed using Clontech SYBR Advan-
tage qPCR premix per the manufacturer’s instructions. Data acquisition was done in QuantStudio3
(Applied Biosystems) and analyzed in QuantStudio design and analysis software (Applied Biosystems).
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Primers are listed in Table S1. Comparative threshold cycle (CT) values were used to evaluate fold change
in transcripts using actin as an internal transcript control.
ELISA for IL-1. Supernatants from samples were collected after centrifugation at 6,000  g for
10 min at RT to avoid cell debris. The supernatants were stored at 80°C if not used immediately. IL-1
levels in the supernatant were measured using the mouse IL-1/IL-1F2 DuoSet enzyme-linked immu-
nosorbent assay (ELISA) kit (R&D Systems) per the manufacturer’s instructions.
Cell viability staining. BMDMs were seeded in 96-well CLEAR black plates. Cells were either
untreated or treated with 10 ng/ml of LPS for 24 h prior to infection or treatment. The cells were infected
with CTG or GT1 parasites at an MOI of 3 for 20 h. Nigericin (10 M) was used to treat cells for 3 h prior
to ﬁxation. As a positive control, 0.1% (wt/vol) saponin treatment for 10 min was used to lyse cells. The
samples were washed once with PBS and stained with the Live/Dead staining kit (Thermo Fisher
Scientiﬁc) containing a mixture of 2 M calcein and 1 M of ethidium homodimer-1 in PBS for 30 min.
The cells were washed with PBS and ﬁxed with 4% formaldehyde for 15 min. The cells were washed with
PBS, imaged using a Cytation3 imager at 20, and analyzed using CellProﬁler 2.1.1.
Statistical analyses. Unpaired two-tailed Student’s t tests were used for comparison between
experiments with normally distributed data using Prism (GraphPad). All experiments were performed at
least three independent times, and statistical analyses were conducted on the composite data unless
reported otherwise. One-way analysis of variance (ANOVA) with Tukey’s multiple-comparison test was
used to compare CTG clearance kinetics in BMDMs. Non-normally distributed data were analyzed using
the Kruskal-Wallis test with Dunn’s correction for multiple tests. Survival statistics were compared using
log rank and Gehan-Breslow-Wilcoxon tests in Prism (GraphPad).
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